Updated Staple Food Stocking Standards for Retailers in the Supplemental Nutrition Assistance Program
The FDA has updated staple food stocking standards for SNAP retailers, but this rule does not directly affect dietary supplement businesses. However, supplement retailers participating in SNAP should review the new requirements to ensure compliance.
Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on July 5, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Supplement brands, contract manufacturers, private-label sellers, and ingredient suppliers that also operate as SNAP-authorized retailers should confirm how it applies to their specific situation before acting. There is a time constraint attached: Comments on the proposed rule are due by November 24, 2025.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The FDA proposed new criteria for what constitutes a 'staple food' for SNAP retailers, including variety and quantity requirements.
Who it affects
Supplement brands, contract manufacturers, private-label sellers, and ingredient suppliers that also operate as SNAP-authorized retailers
What you must do
If you are a SNAP-authorized retailer selling dietary supplements, review the proposed rule to ensure your store meets the new staple food stocking standards.
Deadline
Comments on the proposed rule are due by November 24, 2025.
Never miss a change like this again
Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Dietary-Supplement Labeling (FDA)
- The Dietary Supplement Industry in the Time of Trump: Potential Opportunities and Pitfalls - Food and Drug Law Institute (FDLI)
- 60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement - GlobeNewswire
- After 4-year review, FDA shuts down attempt to regulate CBD as a supplement and asks Congress for help - AgencyIQ by POLITICO
- US FDA New Dietary Ingredient Notification Submissions in the Last 4 Years - CIRS Group
- FDA's 2016 New Dietary Ingredient Draft Guidance - Food and Drug Law Institute (FDLI)